Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds

July 27, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …
News

Expansion for first FDA-approved video game for ADHD treatment

July 23, 2021 Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …
News
cdc-un8tv9pw2ik-unsplash_1

Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …
News
roche__tree

Roche discussing potential Alzheimer’s treatment with FDA

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …
News

NICE approves treatment for rare bile duct cancer

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …
News
catalent

$100 million expansion planned for Catalent’s Italian vaccine plant

July 21, 2021 Manufacturing and Production, Research and Development

Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is …
News

Former FDA adviser calls for further investigation into Alzheimer’s drug

July 21, 2021 Research and Development

A former FDA advisor who resigned after the controversial approval of Biogen’s Alzheimer’s drug has called for a wider probe …
News

Exscientia and Apeiron announce joint oncology venture

July 21, 2021 Research and Development

AI pharmatech company, Exscientia, has announced a collaboration with Shanghai-based GT Apeiron Therapeutics, which will focus on oncology. The strategic …
News

J&J ‘one shot’ vaccine ineffective against Delta variant, study finds

July 21, 2021 Medical Communications, Research and Development

A new study posted online on Tuesday, has found that Johnson & Johnson’s COVID-19 vaccine is much less effective against …
News

More than 13,000 women report period changes after COVID vaccine

July 21, 2021 Research and Development COVID, Vaccine, menstruation, periods

The number of women who have reported changes to their period to the MHRA after having the COVID vaccine has …
News

$26 billion opioid settlement to be unveiled this week in US

July 20, 2021 Manufacturing and Production, Research and Development, Sales and Marketing

US state attorneys general are set to unveil a $26 billion settlement this week, aimed at three major drug distributors …
News

Blood biomarker discovered that can predict COVID-19 infection

July 20, 2021 Manufacturing and Production, Research and Development COVID-19. blood testing, biomarker, gene

Researchers have identified a gene, IFI27, that becomes activated in early stages of COVID-19 even when symptoms are absent, helping …
News

US starts national Medicare review for Biogen’s Alzheimer’s drug

July 14, 2021 Research and Development

The US government has started a review process for national Medicare coverage of Biogen’s controversial Alzheimer’s drug, Aduhelm, that was …
News
astrazeneca_plaque_web

AstraZeneca gets green light for £27.5bn Alexion acquisition

July 14, 2021 Research and Development

AstraZeneca has been given the green light of its $39 billion buyout of US-based rare diseases business Alexion by the …
News
nhs_old_hospital_1

NHS: Cancer backlog to be cleared by March 2022

July 14, 2021 Research and Development

NHS chiefs have announced plans to clear the backlog of cancer patients caused by the pandemic by March 2022. Due …
News
The Gateway to Local Adoption Series

Latest content

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026